| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/04/2006 | US7022718 Pyridine and pyrimidine derivatives |
| 04/04/2006 | US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/04/2006 | US7022711 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones |
| 04/04/2006 | US7022710 A1 adenosine receptor antagonists |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | US7022694 Indoles and indolines having 5-HT activity |
| 04/04/2006 | US7022693 Treatment of lipodystrophy |
| 04/04/2006 | US7022686 A1 adenosine receptro antagonists |
| 04/04/2006 | US7022521 Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
| 04/04/2006 | US7022500 Humanized immunoglobulins |
| 04/04/2006 | US7022339 Antidiabetic preparation for oral administration |
| 04/04/2006 | CA2379521C Methods to identify compounds that modulate rage |
| 04/04/2006 | CA2193039C Indol-2-one derivatives |
| 04/01/2006 | CA2483675A1 Food bar |
| 03/30/2006 | WO2006034463A2 Herbal supplement to support weight loss |
| 03/30/2006 | WO2006034440A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 03/30/2006 | WO2006034312A1 Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd) |
| 03/30/2006 | WO2006033568A1 Synergistic composition for the treatment of diabetes and the comorbidites thereof |
| 03/30/2006 | WO2006033349A1 Total enteral nutritious composition |
| 03/30/2006 | WO2006033341A1 Therapeutic or preventive agent for diabetic neuropathy |
| 03/30/2006 | WO2006033287A1 PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND GLUTATHIONE |
| 03/30/2006 | WO2006033002A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| 03/30/2006 | WO2006033001A1 Quinoline compounds |
| 03/30/2006 | WO2006008656A3 Oatp-c gene c463a polymorphism underlies variable response of statin therapy |
| 03/30/2006 | WO2005123132A3 Use of liver-selective glucokinase activators |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060069259 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus |
| 03/30/2006 | US20060069133 Administering a composition consisting of 2-ethoxy-1-[[2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid, a prodrug thereof or a salt thereof, a PPAR gamma agonist-like substance; diabetes, obesity |
| 03/30/2006 | US20060069131 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 03/30/2006 | US20060069117 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 03/30/2006 | US20060069112 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 03/30/2006 | US20060069100 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity |
| 03/30/2006 | US20060069084 Methods of inhibiting kinases |
| 03/30/2006 | US20060069062 toothpastes, mouthwashes, chewing gums, tableted candy, for inhibiting induction of dental caries |
| 03/30/2006 | US20060068439 Ucp4 |
| 03/30/2006 | US20060068016 Paticulate product comprising pantethine |
| 03/30/2006 | US20060067986 Mixture of milk, protein such as casein and enzyme inhibiting peptide |
| 03/30/2006 | US20060067932 Antagonists specific for denatured collagen and methods of using same |
| 03/30/2006 | DE102004046583A1 New D-xylopyranosyl-phenyl-substituted cycle compounds useful for treating e.g. diabetes mellitus, complications of diabetes, metabolic acidosis or ketosis |
| 03/30/2006 | DE102004046530A1 New bicyclic imidazole derivatives are dipeptidylpeptidase-IV inhibitors useful to treat e.g. arthritis, obesity, allograft transplantation and calcitonin-induced osteoporosis |
| 03/30/2006 | DE102004044555A1 New modification of 2-indenylbutyric acid derivative, useful for treating e.g. diabetes and obesity, thermodynamically stable at room temperature |
| 03/30/2006 | DE102004043944A1 Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel New 8- (3-amino-piperidin-1-yl) -xanthines -7- (but-2-ynyl), their preparation and their use as medicaments |
| 03/30/2006 | CA2581462A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| 03/30/2006 | CA2580860A1 Pyridine derivatives for inhibiting human stearoyl-coa-desaturase |
| 03/30/2006 | CA2580855A1 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 03/30/2006 | CA2580845A1 Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| 03/30/2006 | CA2580787A1 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
| 03/30/2006 | CA2580781A1 Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd) |
| 03/30/2006 | CA2580679A1 Variants and chemically-modified variants of phenylalanine ammonia-lyase |
| 03/30/2006 | CA2579623A1 Agent for treating or preventing diabetic neuropathy |
| 03/29/2006 | EP1640449A1 Cell differentiation inhibiting agent, cell culture method using the same, culture medium and cultured cell line |
| 03/29/2006 | EP1640374A1 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same |
| 03/29/2006 | EP1640015A2 Medicament and dietetic food, comprising cinnamon and extracts of the cinnamon bark and their use |
| 03/29/2006 | EP1640014A1 Remedy |
| 03/29/2006 | EP1639902A1 Movement physiology improver |
| 03/29/2006 | EP1639108A2 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| 03/29/2006 | EP1638970A1 Pyrid (2, 1-a) - isoquinoline derivatives as dpp-iv inhibitors |
| 03/29/2006 | EP1638964A1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 03/29/2006 | EP1638950A2 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/29/2006 | EP1638947A2 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1 |
| 03/29/2006 | EP1638937A2 Fluvastatin sodium crystal forms xiv, lxxiii,lxxix, lxxx and lxxxvii, processes for preparing them, compositions containing them and methods of using them |
| 03/29/2006 | EP1638926A1 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders |
| 03/29/2006 | EP1638925A1 Protease inhibitors |
| 03/29/2006 | EP1638922A1 Pharmaceutically useful salts of carboxylic acid derivates |
| 03/29/2006 | EP1638921A1 Pharmaceutically useful salts of carboxylic acid derivates |
| 03/29/2006 | EP1638586A2 A synergistic composition for the treatment of diabetes mellitus |
| 03/29/2006 | EP1638570A1 Pyrimidine derivatives as cannabinoid receptor ligands |
| 03/29/2006 | EP1638556A1 2-aminobenzothiazoles as cb1 receptor inverse agonists |
| 03/29/2006 | EP1638555A1 Substituted 5-membered ring compounds and their use |
| 03/29/2006 | EP1638554A1 Compositions comprising balaglitazone and further antidiabetic compounds |
| 03/29/2006 | EP1638545A1 Combination comprising s-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]2-methylpropanethioate and an hmg coa reductase inhibitor |
| 03/29/2006 | EP1572707B1 Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof |
| 03/29/2006 | EP1492792B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino¬4,5-b|indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 03/29/2006 | EP1467998B1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 03/29/2006 | EP1385496A4 Use of compositions for treating rosacea |
| 03/29/2006 | EP1358354B1 Method for identifying compounds modulating reverse cholesterol transport |
| 03/29/2006 | EP1214048B1 Use of conjugated linoleic acid (cla) for the topical treatment of cellulite |
| 03/29/2006 | EP1212601A4 Glucose biosensor |
| 03/29/2006 | EP1005490B1 Zinc free insulin crystals for use in pulmonary compositions |
| 03/29/2006 | EP0751709B2 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 03/29/2006 | CN1753887A Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1753886A Process for producing acid adduct salt of polyacidic base compound |
| 03/29/2006 | CN1753881A 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis. |
| 03/29/2006 | CN1753880A Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1753879A (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexylmethoxy acetic acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis. |
| 03/29/2006 | CN1753877A Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 03/29/2006 | CN1753865A Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1753671A 1,3-substitued cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1753670A Novel derivatives of benzimidazole and imidazo-pyridine and their use as medicaments |
| 03/29/2006 | CN1751717A Compound composition for preventing and treating diabetes and its prepn. method |
| 03/29/2006 | CN1751694A Polyporus frondosus oral liquor and its prodn. method |
| 03/29/2006 | CN1751693A Application of astragaloside in medicine for treating or preventing insulin resistance |
| 03/29/2006 | CN1751598A Diet-therapy product prodn. method |
| 03/29/2006 | CN1248514C Method and an arrangement for connecting and disconnecting communications links |
| 03/29/2006 | CN1247784C Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 03/29/2006 | CN1247616C New monomeric insulin, its medicinal composition and prepn process |
| 03/29/2006 | CN1247589C Tricyclic derivatives of indole with antiangiogenic activity |
| 03/29/2006 | CN1247586C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 03/29/2006 | CN1247585C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives |
| 03/29/2006 | CN1247584C I-[alkyl] 1-[(heteroaryl) alkyl] and 1 [(aryl) alkyl] 7-pyridinyl-imidazo [1,2-a] pyrimidin-5(1h)-one derivatives |